120 related articles for article (PubMed ID: 16469059)
1. Strong immunostimulatory activity of AT-oligodeoxynucleotide requires a six-base loop with a self-stabilized 5'-C...G-3' stem structure.
Shimosato T; Kimura T; Tohno M; Iliev ID; Katoh S; Ito Y; Kawai Y; Sasaki T; Saito T; Kitazawa H
Cell Microbiol; 2006 Mar; 8(3):485-95. PubMed ID: 16469059
[TBL] [Abstract][Full Text] [Related]
2. Augmentation of T(H)-1 type response by immunoactive AT oligonucleotide from lactic acid bacteria via Toll-like receptor 9 signaling.
Shimosato T; Kitazawa H; Katoh S; Tohno M; Iliev ID; Nagasawa C; Kimura T; Kawai Y; Saito T
Biochem Biophys Res Commun; 2005 Jan; 326(4):782-7. PubMed ID: 15607737
[TBL] [Abstract][Full Text] [Related]
3. In vivo oral administration effects of various oligodeoxynucleotides containing synthetic immunostimulatory motifs in the immune response to pseudorabies attenuated virus vaccine in newborn piglets.
Linghua Z; Xingshan T; Fengzhen Z
Vaccine; 2008 Jan; 26(2):224-33. PubMed ID: 18063448
[TBL] [Abstract][Full Text] [Related]
4. Identification of a potent immunostimulatory oligodeoxynucleotide from Streptococcus thermophilus lacZ.
Shimosato T; Tohno M; Sato T; Nishimura J; Kawai Y; Saito T; Kitazawa H
Anim Sci J; 2009 Oct; 80(5):597-604. PubMed ID: 20163626
[TBL] [Abstract][Full Text] [Related]
5. Immunostimulatory oligodeoxynucleotide isolated from genome wide screening of Mycobacterium bovis chromosomal DNA.
Lee KW; Jung J; Lee Y; Kim TY; Choi SY; Park J; Kim DS; Kwon HJ
Mol Immunol; 2006 May; 43(13):2107-18. PubMed ID: 16442622
[TBL] [Abstract][Full Text] [Related]
6. Differentiated implication of Lactobacillus GG and L. gasseri TMC0356 to immune responses of murine Peyer's patch.
Harata G; He F; Kawase M; Hosono A; Takahashi K; Kaminogawa S
Microbiol Immunol; 2009 Aug; 53(8):475-80. PubMed ID: 19659932
[TBL] [Abstract][Full Text] [Related]
7. The critical DNA flanking sequences of a CpG oligodeoxynucleotide, but not the 6 base CpG motif, can be replaced with RNA without quantitative or qualitative changes in Toll-like receptor 9-mediated activity.
Sen G; Flora M; Chattopadhyay G; Klinman DM; Lees A; Mond JJ; Snapper CM
Cell Immunol; 2004; 232(1-2):64-74. PubMed ID: 15922717
[TBL] [Abstract][Full Text] [Related]
8. Identification of CpG oligodeoxynucleotide sequences that induce IFN-gamma production in canine peripheral blood mononuclear cells.
Kurata K; Iwata A; Masuda K; Sakaguchi M; Ohno K; Tsujimoto H
Vet Immunol Immunopathol; 2004 Dec; 102(4):441-50. PubMed ID: 15541797
[TBL] [Abstract][Full Text] [Related]
9. A novel antagonist of TLR9 blocking all classes of immunostimulatory CpG-ODNs.
Li Y; Cao H; Wang N; Xiang Y; Lu Y; Zhao K; Zheng J; Zhou H
Vaccine; 2011 Mar; 29(11):2193-8. PubMed ID: 21036131
[TBL] [Abstract][Full Text] [Related]
10. Novel immunostimulatory agent based on CpG oligodeoxynucleotide linked to the nontoxic B subunit of cholera toxin.
Adamsson J; Lindblad M; Lundqvist A; Kelly D; Holmgren J; Harandi AM
J Immunol; 2006 Apr; 176(8):4902-13. PubMed ID: 16585586
[TBL] [Abstract][Full Text] [Related]
11. Synthetic methylated CpG ODNs are potent in vivo adjuvants when delivered in liposomal nanoparticles.
Chikh G; de Jong SD; Sekirov L; Raney SG; Kazem M; Wilson KD; Cullis PR; Dutz JP; Tam YK
Int Immunol; 2009 Jul; 21(7):757-67. PubMed ID: 19502586
[TBL] [Abstract][Full Text] [Related]
12. An immunostimulatory DNA sequence from a probiotic strain of Bifidobacterium longum inhibits IgE production in vitro.
Takahashi N; Kitazawa H; Shimosato T; Iwabuchi N; Xiao JZ; Iwatsuki K; Kokubo S; Saito T
FEMS Immunol Med Microbiol; 2006 Apr; 46(3):461-9. PubMed ID: 16553822
[TBL] [Abstract][Full Text] [Related]
13. The adjuvant effect of CpG oligodeoxynucleotide linked to the non-toxic B subunit of cholera toxin for induction of immunity against H. pylori in mice.
Nyström-Asklin J; Adamsson J; Harandi AM
Scand J Immunol; 2008 May; 67(5):431-40. PubMed ID: 18298617
[TBL] [Abstract][Full Text] [Related]
14. Effect of growth conditions of Lactobacillus gasseri OLL2809 on the immunostimulatory activity for production of interleukin-12 (p70) by murine splenocytes.
Sashihara T; Sueki N; Furuichi K; Ikegami S
Int J Food Microbiol; 2007 Dec; 120(3):274-81. PubMed ID: 17936392
[TBL] [Abstract][Full Text] [Related]
15. Strong immunostimulation in murine immune cells by Lactobacillus rhamnosus GG DNA containing novel oligodeoxynucleotide pattern.
Iliev ID; Kitazawa H; Shimosato T; Katoh S; Morita H; He F; Hosoda M; Saito T
Cell Microbiol; 2005 Mar; 7(3):403-14. PubMed ID: 15679843
[TBL] [Abstract][Full Text] [Related]
16. Chicken TLR21 acts as a functional homologue to mammalian TLR9 in the recognition of CpG oligodeoxynucleotides.
Brownlie R; Zhu J; Allan B; Mutwiri GK; Babiuk LA; Potter A; Griebel P
Mol Immunol; 2009 Sep; 46(15):3163-70. PubMed ID: 19573927
[TBL] [Abstract][Full Text] [Related]
17. The newly identified CpG-N ODN208 protects mice from challenge with CpG-S ODN by decreasing TNF-alpha release.
Wang L; Jiang W; Ding G; Cao H; Lu Y; Luo P; Zhou H; Zheng J
Int Immunopharmacol; 2007 May; 7(5):646-55. PubMed ID: 17386412
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor 9 mediates CpG oligonucleotide-induced cellular invasion.
Ilvesaro JM; Merrell MA; Li L; Wakchoure S; Graves D; Brooks S; Rahko E; Jukkola-Vuorinen A; Vuopala KS; Harris KW; Selander KS
Mol Cancer Res; 2008 Oct; 6(10):1534-43. PubMed ID: 18922969
[TBL] [Abstract][Full Text] [Related]
19. Agonists of Toll-like receptor 9 containing synthetic dinucleotide motifs.
Yu D; Putta MR; Bhagat L; Li Y; Zhu F; Wang D; Tang JX; Kandimalla ER; Agrawal S
J Med Chem; 2007 Dec; 50(25):6411-8. PubMed ID: 17988082
[TBL] [Abstract][Full Text] [Related]
20. Novel oligodeoxynucleotide agonists of TLR9 containing N3-Me-dC or N1-Me-dG modifications.
Putta MR; Zhu F; Li Y; Bhagat L; Cong Y; Kandimalla ER; Agrawal S
Nucleic Acids Res; 2006; 34(11):3231-8. PubMed ID: 16798912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
